Clinical trials
Phase 3 Lymphoma, T-Cell, Peripheral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Completed | 5 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aarhus University Hospital | 1 |
| Acrotech Biopharma Inc. | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Chipscreen Biosciences, Ltd. | 1 |
| Corvus Pharmaceuticals, Inc. | 1 |
| Dizal Pharmaceuticals | 1 |
| Eisai Inc. | 1 |
| Evopoint Biosciences Inc. | 1 |
| Fudan University | 1 |
| Jennifer Amengual | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 22 |
| Lymphoma, T-Cell | 4 |
| Immunoblastic Lymphadenopathy | 3 |
| Lymphoma | 2 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Lymphoproliferative Disorders | 1 |
| Recurrence | 1 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.